Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency.
Abstract
BACKGROUND
The development of COPD in subjects with alpha-1 antitrypsin (AAT) deficiency is likely to be influenced by modifier genes.
Genome-wide association studies and integrative genomics approaches in COPD have demonstrated significant associations with
SNPs in the chromosome 15q region that includes CHRNA3 (cholinergic nicotine receptor alpha3) and IREB2 (iron regulatory binding
protein 2).We investigated whether SNPs in the chromosome 15q region would be modifiers for lung function and COPD in AAT
deficiency.
METHODS
The current analysis included 378 PIZZ subjects in the AAT Genetic Modifiers Study and a replication cohort of 458 subjects
from the UK AAT Deficiency National Registry. Nine SNPs in LOC123688, CHRNA3 and IREB2 were selected for genotyping. FEV1
percent of predicted and FEV1/FVC ratio were analyzed as quantitative phenotypes. Family-based association analysis was performed
in the AAT Genetic Modifiers Study. In the replication set, general linear models were used for quantitative phenotypes and
logistic regression models were used for the presence/absence of emphysema or COPD.
RESULTS
Three SNPs (rs2568494 in IREB2, rs8034191 in LOC123688, and rs1051730 in CHRNA3) were associated with pre-bronchodilator FEV1
percent of predicted in the AAT Genetic Modifiers Study. Two SNPs (rs2568494 and rs1051730) were associated with the post-bronchodilator
FEV1 percent of predicted and pre-bronchodilator FEV1/FVC ratio; SNP-by-gender interactions were observed. In the UK National
Registry dataset, rs2568494 was significantly associated with emphysema in the male subgroup; significant SNP-by-smoking interactions
were observed.
CONCLUSIONS
IREB2 and CHRNA3 are potential genetic modifiers of COPD phenotypes in individuals with severe AAT deficiency and may be sex-specific
in their impact.
Links
Authors
Kim WJ, Wood AM, Barker AF, Brantly ML, Campbell EJ, Eden E, McElvaney G, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK, Stockley RA, Demeo DL
Institution
Channing Laboratory and the Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Source
Respiratory research 13: 2012 pg 16MeSH
AdultChromosomes, Human, Pair 15
Female
Humans
Iron Regulatory Protein 2
Male
Middle Aged
Polymorphism, Single Nucleotide
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Receptors, Nicotinic
Respiratory Function Tests
Severity of Illness Index
Sex Factors
alpha 1-Antitrypsin Deficiency
Pub Type(s)
Journal ArticleResearch Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
22356581
Log In

